![](/img/cover-not-exists.png)
Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life
Pol, Stanislas, Vallet-Pichard, Anaïs, Corouge, MarionLanguage:
english
Journal:
Hepatic Medicine: Evidence and Research
DOI:
10.2147/HMER.S62014
Date:
March, 2016
File:
PDF, 228 KB
english, 2016